Alpha-GPC (alpha-glycerylphosphorylcholine) is one of the better-evidenced cognitive supplements with a wide therapeutic window. The dose questions are mostly settled: 300 to 600 mg per day for daily cognitive baseline, 600 mg pre-training for acute power output, 1,200 mg per day for clinical use in vascular cognitive impairment. This guide walks through the dose selection logic by goal and the timing patterns that matter.
What is alpha-GPC and why does dose matter?
Alpha-GPC is a choline donor that crosses the blood-brain barrier efficiently and serves as a substrate for acetylcholine synthesis. Roughly 40% of its weight is bioavailable choline, the highest yield of any common choline source. It is sold as a dietary supplement in the US and other markets, and as a prescription cognitive medication (Gliatilin, Delecit) in much of Europe at 1,200 mg/day.
Dose matters because acetylcholine has an inverted-U dose-response curve. Too little produces no effect; too much produces headache, irritability, and parasympathetic symptoms (excess salivation, GI distress). The sweet spot for healthy adults is between 300 and 1,200 mg/day depending on goal, with 600 mg being the most-replicated single dose in cognitive and power-output trials.
The compound has been used clinically for vascular cognitive impairment since the 1980s in Italy and several other European countries. The clinical use case (1,200 mg/day for years) provides the upper-bound safety data that the consumer market draws on.
Dose by goal
The cleanest way to choose a dose is to start with the goal.
Daily cognitive baseline: 300 to 600 mg/day
For users wanting steady cognitive support without acute peaks, 300 mg in the morning is the minimum effective dose and 600 mg/day (300 mg AM + 300 mg early afternoon, or 600 mg AM in one dose) is the upper end of the daily-baseline range. The Ziegenfuss 2008 trial and several smaller human trials cluster at 600 mg/day for cognitive endpoints in healthy adults.
Expect subjective effects within 7 to 14 days of daily use. Verbal-memory tasks and reaction-time tests show modest improvements in trials. The effect is real but small; alpha-GPC is one component of a cognitive stack, not a standalone cognitive intervention.
Acute focus / pre-task: 300 to 600 mg single dose
For acute cognitive enhancement (a meeting, a difficult task, a long study session), a single 300 to 600 mg dose 30 to 45 minutes before the task produces noticeable focus and verbal-fluency improvements. Pair with caffeine 100 to 200 mg + L-theanine 100 to 200 mg for the canonical morning-stack pattern; the three compounds target distinct mechanisms.
The acute-dose case is well-established but not as well-trial-replicated as the chronic baseline case. Effects are modest but consistent across users.
Pre-training power output: 600 mg, 45 to 60 minutes before training
The Bellar 2015 trial reported significant improvements in lower-body force production at 600 mg alpha-GPC taken 45 minutes before training Bellar D et al 2015 . Subsequent trials have replicated the power-output finding at similar doses and timing. The mechanism is plausibly via increased acetylcholine availability at the neuromuscular junction.
For lifters and power athletes, the 600 mg pre-training dose is the most-supported single use of alpha-GPC. Effects are most pronounced on explosive movements (vertical jump, isometric mid-thigh pull) and less on endurance.
Vascular cognitive impairment / Alzheimer's adjunct: 1,200 mg/day
The clinical Rx dose in Europe is 1,200 mg/day divided (400 mg three times daily), used for vascular cognitive impairment, post-stroke recovery, and as an adjunct in mild-to-moderate Alzheimer's. The De Jesus Moreno Moreno 2003 trial (n=261, 1,200 mg/day for 6 months in mild-moderate Alzheimer's) reported improved cognitive scores vs placebo De Jesus Moreno Moreno M 2003 . Effect sizes are modest but consistent.
This dose is not a typical consumer-supplement target. Users with diagnosed cognitive impairment should run dose decisions through a specialist; the clinical trial protocols are well-established and self-administration is rare.
Above 1,200 mg/day: no demonstrated incremental benefit
Trials above 1,200 mg/day have not been systematically conducted. Anecdotal reports of higher doses (1,800 to 2,400 mg/day) in nootropic communities exist but lack trial support. The likely answer is plateau: above 1,200 mg/day, additional alpha-GPC produces increased side effect risk (headache, GI distress) without demonstrable cognitive benefit.
The dose-response data we have stops at 1,200 mg/day. Going higher is empirical and not recommended.
Timing patterns that matter
Morning empty stomach is the conventional pattern for daily cognitive use. Absorption is fast (peak plasma in 30 to 60 minutes); empty-stomach dosing produces predictable timing.
With food works equally well for absorption but delays peak by ~30 minutes. For users who have GI sensitivity, with-food dosing reduces the rare GI side effects.
Pre-training: 45 to 60 minutes before the session, on an empty stomach if possible. The Bellar protocol used this timing.
Avoid evening dosing. Choline upregulation may interfere with sleep onset for some users; the mechanistic case is dopamine elevation at the wrong end of the day. Daytime use only.
Side effects: when to reduce dose
The hallmark side effect of too-much-alpha-GPC is headache, often frontal or temporal. Acetylcholine excess in the brain produces this pattern. If headache appears within 30 to 90 minutes of dosing, reduce the dose by 50% next time and reassess.
Other dose-dependent effects: GI distress (nausea, loose stools), fatigue (paradoxically, at very high acute doses), and occasional irritability. All resolve with dose reduction.
The compound is generally well-tolerated below 1,200 mg/day. Above this dose, side effects become more common and benefits do not increase proportionally.
Stacking alpha-GPC
The most-evidenced pairings:
- Caffeine + L-theanine: 100-200 mg of each + 300-600 mg alpha-GPC, 30-45 min before focus block. The three compounds target distinct mechanisms; combination is well-tolerated.
- Citicoline (CDP-choline): alternate choline donor; do not stack with alpha-GPC at full doses (additive choline excess causes headache). Pick one or alternate.
- Racetams (piracetam, aniracetam): classic nootropic-community pairing; mechanistic rationale is acetylcholine support during racetam-driven receptor activation. Trial evidence is thin.
- Pre-workout supplements: alpha-GPC 600 mg pre-training pairs with caffeine, beta-alanine, citrulline. The cardiovascular load is acceptable; watch heart rate response.
The nootropic stacks honest guide covers the broader stacking framework.
Practical: how to start alpha-GPC
A sensible introduction protocol:
- Days 1-7: 300 mg AM, single dose, with breakfast. Track subjective focus and any headache.
- Days 8-14: 600 mg AM, single dose, if 300 mg was well-tolerated. Reassess subjective effect and side effects.
- Day 14 onward: settle at the lowest effective dose. For most users this is 300 to 600 mg/day.
- Pre-training override: on training days, use 600 mg 45 to 60 minutes pre-session if power output is the goal.
- Beyond 600 mg/day: only with a specific clinical reason; vascular cognitive impairment justifies 1,200 mg/day under specialist guidance.
See the alpha-GPC compound page for the mechanism + side-effects detail. For dosage guidance across other compounds, the dosage guides directory covers 50+ compound-specific protocols.
